Project Optimus: helping or hindering cancer drug development?
Experts say that Project Optimus is a necessary reform in the oncology space, but one that should be applied with caution.
Source: yahoo.com
Dose Optimization News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dose Optimization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dose Optimization Today - Breaking & Trending Today
Treatment and Dose Optimization in HR+/HER2- Early Breast Cancer
A comprehensive discussion on approaches to optimizing treatment selection and dosing in HR+/HER2- breast cancer.
Source: onclive.com
Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 ASCO Annual Meeting
Poster Discussion Features Investigational Safety and Efficacy Data from the Platinum-Resistant Ovarian Cancer Cohort Expansion of a Phase 1 Study Evaluating Farletuzumab Ecteribulin (MORAb-202) in Solid
Source: finanznachrichten.de
Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 ASCO Annual Meeting
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
EULAR Suggested New Points on Drug Monitoring in Rheumatic Disease
New EULAR points were developed by a multidisciplinary task force from eight European countries with health care professionals from various branches.
Source: medindia.net